Crossmark

Repeated measures of Heparin-binding protein (HBP) and procalcitonin during septic shock: biomarker kinetics and association with cardiovascular organ dysfunction

Crossref DOI link: https://doi.org/10.1186/s40635-020-00338-8

Published Online: 2020-09-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tverring, Jonas https://orcid.org/0000-0003-0939-6673
Nielsen, Niklas

Dankiewicz, Josef

Linder, Adam

Kahn, Fredrik

Åkesson, Per
Funding

Funding for this research was provided by:

Thelma Zoégas Foundation for medical research (91282)

Swedish Government Research Grant (ST ALF 2016-2018 and 2020-2022)

Svenska Läkaresällskapet

Alfred Österlunds Stiftelse

Hjärt-Lungfonden

Vetenskapsrådet
License Information

Text and Data Mining valid from 2020-09-10

Version of Record valid from 2020-09-10
More Information

Article History

Received: 18 May 2020

Accepted: 14 August 2020

First Online: 10 September 2020

Ethics approval and consent to participate

: The Regional Ethical Review Board at Lund University approved the study design in the year 2014 and 2016 (Dnr 2014/741 and 2016/271). Each participant or his/her proxy gave written informed consent to participate in the study.

: Not applicable.

: AL and PÅ are listed as inventors on a pending patent application on the use of HBP as a diagnostic tool in sepsis filed by Hansa Medical AB. The other authors declare that they have no competing interests.

Document is current

Any future updates will be listed below